Free Trial

RUA Life Sciences (RUA) Competitors

RUA Life Sciences logo
GBX 11.33 -0.42 (-3.55%)
As of 04/25/2025 12:20 PM Eastern

RUA vs. NCYT, POLX, IHC, AVO, MHC, SUN, BELL, DEMG, NIOX, and SN

Should you be buying RUA Life Sciences stock or one of its competitors? The main competitors of RUA Life Sciences include Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), MyHealthChecked (MHC), Surgical Innovations Group (SUN), Belluscura (BELL), Deltex Medical Group (DEMG), NIOX Group (NIOX), and Smith & Nephew (SN). These companies are all part of the "medical devices" industry.

RUA Life Sciences vs.

RUA Life Sciences (LON:RUA) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, media sentiment, dividends, institutional ownership, community ranking and earnings.

RUA Life Sciences has a net margin of -65.72% compared to Novacyt's net margin of -203.06%. RUA Life Sciences' return on equity of -26.38% beat Novacyt's return on equity.

Company Net Margins Return on Equity Return on Assets
RUA Life Sciences-65.72% -26.38% -17.50%
Novacyt -203.06%-47.73%-27.98%

RUA Life Sciences has higher earnings, but lower revenue than Novacyt. RUA Life Sciences is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RUA Life Sciences£4.05M1.74-£2.66M-£4.29-2.64
Novacyt£18.12M1.46-£36.80M-£54.44-0.70

RUA Life Sciences has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, indicating that its stock price is 286% less volatile than the S&P 500.

Novacyt received 36 more outperform votes than RUA Life Sciences when rated by MarketBeat users. Likewise, 58.06% of users gave Novacyt an outperform vote while only 0.00% of users gave RUA Life Sciences an outperform vote.

CompanyUnderperformOutperform
RUA Life SciencesOutperform Votes
No Votes
Underperform Votes
6
100.00%
NovacytOutperform Votes
36
58.06%
Underperform Votes
26
41.94%

In the previous week, RUA Life Sciences' average media sentiment score of 0.00 equaled Novacyt'saverage media sentiment score.

Company Overall Sentiment
RUA Life Sciences Neutral
Novacyt Neutral

26.0% of RUA Life Sciences shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 51.3% of RUA Life Sciences shares are held by insiders. Comparatively, 3.1% of Novacyt shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

RUA Life Sciences beats Novacyt on 9 of the 13 factors compared between the two stocks.

Get RUA Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RUA and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RUA vs. The Competition

MetricRUA Life SciencesMedical Devices IndustryMedical SectorLON Exchange
Market Cap£7.03M£3.16B£5.44B£2.55B
Dividend Yield1.44%2.45%5.43%4.83%
P/E Ratio-2.6466.2822.14132.21
Price / Sales1.74117.42389.70240,567.81
Price / Cash2.4015.9938.2028.16
Price / Book0.533.666.664.51
Net Income-£2.66M£126.02M£3.21B£5.83B
7 Day Performance-4.36%0.21%6.16%8.59%
1 Month Performance-3.14%-7.84%-2.86%6.39%
1 Year Performance5.42%-14.94%16.43%103.27%

RUA Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RUA
RUA Life Sciences
N/AGBX 11.33
-3.5%
N/A+10.7%£7.03M£4.05M-2.6448Gap Up
High Trading Volume
NCYT
Novacyt
N/AGBX 40.07
-1.6%
N/A-44.5%£27.68M£18.12M-0.74120
POLX
Polarean Imaging
N/AGBX 1.08
+4.9%
N/A-71.8%£15.78M£5.21M-0.2828High Trading Volume
IHC
Inspiration Healthcare Group
N/AGBX 16.65
+0.9%
N/A-46.4%£14.42M£42.87M-1.14224Positive News
Gap Down
AVO
Advanced Oncotherapy
N/AN/AN/AN/A£9.50MN/A-25.003,900Gap Down
MHC
MyHealthChecked
N/AGBX 14
-3.4%
N/A+40.0%£7.29M£9.43M-6.9816Gap Down
SUN
Surgical Innovations Group
N/AGBX 0.51
-2.3%
N/A+5.6%£4.79M£12.54M-21.1180News Coverage
Gap Down
BELL
Belluscura
N/AGBX 0.69
+2.1%
N/A-91.0%£1.74M£2.87M-0.0724Gap Down
DEMG
Deltex Medical Group
N/AN/AN/AN/A£187,000.00£1.76M-0.1537Gap Up
High Trading Volume
NIOX
NIOX Group
2.0501 of 5 stars
GBX 61
-1.6%
GBX 90
+47.5%
-9.2%£25.05B£3.53B2,517.3692Gap Down
SN
Smith & Nephew
3.452 of 5 stars
GBX 980
-0.4%
GBX 4,607.50
+370.2%
+2.1%£10.74B£7.08B35.2818,452News Coverage
High Trading Volume

Related Companies and Tools


This page (LON:RUA) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners